A detailed history of Virtus ETF Advisers LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 1,145 shares of UTHR stock, worth $417,157. This represents 0.2% of its overall portfolio holdings.

Number of Shares
1,145
Previous 1,145 -0.0%
Holding current value
$417,157
Previous $364,000 12.64%
% of portfolio
0.2%
Previous 0.19%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$228.26 - $319.04 $81,032 - $113,259
-355 Reduced 23.67%
1,145 $364,000
Q1 2024

May 15, 2024

BUY
$210.76 - $249.51 $45,524 - $53,894
216 Added 16.82%
1,500 $344,000
Q4 2023

Feb 15, 2024

SELL
$214.88 - $256.94 $12,463 - $14,902
-58 Reduced 4.32%
1,284 $282,000
Q3 2023

Nov 07, 2023

SELL
$211.82 - $248.24 $37,492 - $43,938
-177 Reduced 11.65%
1,342 $303,000
Q2 2023

Aug 14, 2023

BUY
$205.19 - $232.99 $83,307 - $94,593
406 Added 36.48%
1,519 $335,000
Q1 2023

May 15, 2023

BUY
$212.99 - $276.17 $4,259 - $5,523
20 Added 1.83%
1,113 $249,000
Q4 2022

Feb 14, 2023

BUY
$205.95 - $280.43 $3,295 - $4,486
16 Added 1.49%
1,093 $303,000
Q3 2022

Nov 14, 2022

BUY
$203.3 - $244.17 $2,846 - $3,418
14 Added 1.32%
1,077 $226,000
Q2 2022

Aug 12, 2022

SELL
$174.81 - $241.14 $149,462 - $206,174
-855 Reduced 44.58%
1,063 $250,000
Q4 2021

Feb 14, 2022

SELL
$184.32 - $216.08 $116,121 - $136,130
-630 Reduced 24.73%
1,918 $414,000
Q3 2021

Nov 15, 2021

SELL
$179.86 - $214.88 $41,547 - $49,637
-231 Reduced 8.31%
2,548 $470,000
Q2 2021

Aug 10, 2021

SELL
$170.47 - $211.93 $272,240 - $338,452
-1,597 Reduced 36.49%
2,779 $499,000
Q1 2021

May 17, 2021

BUY
$153.94 - $174.85 $19,088 - $21,681
124 Added 2.92%
4,376 $732,000
Q4 2020

Feb 12, 2021

SELL
$101.87 - $151.79 $82,718 - $123,253
-812 Reduced 16.03%
4,252 $645,000
Q3 2020

Nov 13, 2020

BUY
$99.9 - $121.13 $42,657 - $51,722
427 Added 9.21%
5,064 $511,000
Q2 2020

Aug 05, 2020

SELL
$92.74 - $125.82 $178,988 - $242,832
-1,930 Reduced 29.39%
4,637 $561,000
Q1 2020

May 14, 2020

SELL
$79.39 - $115.35 $43,982 - $63,903
-554 Reduced 7.78%
6,567 $623,000
Q4 2019

Feb 13, 2020

SELL
$78.31 - $95.34 $135,867 - $165,414
-1,735 Reduced 19.59%
7,121 $627,000
Q3 2019

Nov 12, 2019

SELL
$74.85 - $85.99 $111,676 - $128,297
-1,492 Reduced 14.42%
8,856 $706,000
Q2 2019

Aug 13, 2019

BUY
$76.06 - $120.81 $248,259 - $394,323
3,264 Added 46.08%
10,348 $808,000
Q1 2019

May 14, 2019

BUY
$107.15 - $126.84 $165,868 - $196,348
1,548 Added 27.96%
7,084 $831,000
Q4 2018

Feb 05, 2019

SELL
$101.4 - $128.73 $133,848 - $169,923
-1,320 Reduced 19.25%
5,536 $603,000
Q3 2018

Nov 14, 2018

BUY
$113.81 - $129.46 $52,580 - $59,810
462 Added 7.23%
6,856 $877,000
Q2 2018

Aug 10, 2018

SELL
$101.14 - $118.31 $31,757 - $37,149
-314 Reduced 4.68%
6,394 $723,000
Q1 2018

May 14, 2018

SELL
$107.21 - $151.94 $41,811 - $59,256
-390 Reduced 5.49%
6,708 $754,000
Q4 2017

Feb 14, 2018

SELL
$118.58 - $151.28 $101,267 - $129,193
-854 Reduced 10.74%
7,098 $1.05 Million
Q2 2017

Aug 14, 2017

BUY
N/A
7,952
7,952 $1.03 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.